Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease

NCT07372781 is registered in ClinicalTrials.gov with Beijing Chest Hospital as lead sponsor.

NCT NCT07372781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07372781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease
Lead sponsor
Beijing Chest Hospital
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
January 1, 2026
Completion date
December 31, 2026
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

monotherapy, mycobacterium abscessus infection